Tag: CAPA

Training Study Teams on the Analytical Consequences of Non-Compliance Training Study Teams on the Analytical Consequences of Non-Compliance The success of a clinical trial not only hinges on the efficacy of the treatment being tested but is also critically influenced by the adherence to regulatory standards and protocols by all study personnel involved. This article…

Read More “Training Study Teams on the Analytical Consequences of Non-Compliance” »

Handling DCT-Specific Deviations in Exposure and Adherence Data Decentralized Clinical Trials (DCTs) have gained traction in recent years, prompting clinical trial researchers to navigate unique challenges associated with remote data collection, including deviations in exposure and adherence data. In this tutorial, we will explore the effective handling of DCT-specific deviations, focusing on strategies that align…

Read More “Handling DCT-Specific Deviations in Exposure and Adherence Data” »

Aligning Deviation Data Handling With Labeling and Risk Management Aligning Deviation Data Handling With Labeling and Risk Management In the realm of clinical trials, effective data handling and management processes are critical for ensuring compliance with regulatory standards, facilitating sound decision-making, and maintaining patient safety. With increasing scrutiny from regulatory bodies such as the FDA,…

Read More “Aligning Deviation Data Handling With Labeling and Risk Management” »

Deviation-Driven Sensitivity Analyses That Strengthen Regulatory Confidence The integrity of clinical trial data is essential for regulatory confidence and the successful approval of new therapies. With increasing scrutiny from regulatory bodies such as the FDA, EMA, and MHRA, it is paramount for clinical researchers to properly handle and analyze protocol deviations. This guide will provide…

Read More “Deviation-Driven Sensitivity Analyses That Strengthen Regulatory Confidence” »

Case Studies: Deviations That Changed Primary Analysis Conclusions Case Studies: Deviations That Changed Primary Analysis Conclusions In the landscape of clinical trials, the integrity of data and compliance with set protocols are pivotal to achieving valid results. This comprehensive tutorial explores real-world case studies of deviations in clinical trials, particularly their ramifications on primary analysis…

Read More “Case Studies: Deviations That Changed Primary Analysis Conclusions” »

Collaborating With Biostatistics to Assess Deviation Impact on Power In the ever-evolving field of clinical research, the analysis of protocol deviations is critical for ensuring the integrity of study outcomes. Understanding the impact of these deviations on the statistical power of a trial requires a thorough collaboration between clinical operations teams and biostatisticians. This guide…

Read More “Collaborating With Biostatistics to Assess Deviation Impact on Power” »

Documenting Data Handling Decisions for Inspectors and HTA Bodies In the landscape of clinical trials, the need for meticulous documentation of data handling decisions cannot be overstated. Regulatory agencies including the FDA, EMA, and MHRA scrutinize these aspects during inspections and evaluations. This article serves as a comprehensive tutorial for clinical operations, regulatory affairs, and…

Read More “Documenting Data Handling Decisions for Inspectors and HTA Bodies” »

Pre-Specifying Deviation Handling in SAPs and Estimand Frameworks Pre-Specifying Deviation Handling in Statistical Analysis Plans (SAPs) and Estimand Frameworks The success of clinical trials, particularly in areas such as prostate cancer clinical trials, hinges on the meticulous handling of protocol deviations. The emergence of the estimand framework has brought to light the importance of pre-specifying…

Read More “Pre-Specifying Deviation Handling in SAPs and Estimand Frameworks” »

Data Censoring, Exclusion and Flagging Strategies for Deviations Data Censoring, Exclusion and Flagging Strategies for Deviations in Clinical Trials The handling of data in clinical trials is a critical aspect of maintaining the integrity of study results, especially when deviations occur. A systematic approach to data censoring, exclusion, and flagging is essential for ensuring compliance…

Read More “Data Censoring, Exclusion and Flagging Strategies for Deviations” »

Defining Per-Protocol, ITT and Sensitivity Populations in Light of Deviations Defining Per-Protocol, ITT and Sensitivity Populations in Light of Deviations The significance of data integrity in clinical trials cannot be overstated. In designing clinical trials, particularly those focused on high-stakes medical conditions like prostate cancer, it is vital to understand how different study populations impact…

Read More “Defining Per-Protocol, ITT and Sensitivity Populations in Light of Deviations” »